Wegovy

arrow back backwards u-turn turn around reverse
Favicon Fierce Pharma

Hims quits on obesity pill after legal, regulatory heat

Hims has quickly retreated from its launch of a compounded obesity pill after facing mounting pressure from the FDA and Novo Nordisk.
Fraiser Kansteiner Feb 9, 2026 10:24am
Makary
Favicon Fierce Pharma

FDA commissioner pledges crackdown on compounding practices

Feb 6, 2026 9:59am
A woman in a lab coat standing in front of a green background with Hims Hers branded products floating around her

Hims & Hers plans to launch $49 copy of Wegovy pill

Feb 5, 2026 1:00pm
The outside of Optums headquarters

Optum Rx: Why payers should be watching these 3 pipeline drugs

Nov 26, 2025 1:30pm
White House
Favicon Fierce Pharma

Lilly, Novo reach GLP-1 pricing deals with White House

Nov 6, 2025 12:26pm
smartphones with screenshots of Talkspace mental health app

Talkspace boosts AI innovation, inks Novo Nordisk partnership

Oct 31, 2025 1:00pm